A more efficient DNA technology to detect and treat infectious diseases and cancer has been developed by researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR.
The researchers improved on existing technologies to create a modified single-stranded DNA molecule called aptamer. DNA aptamers are ideal for pharmaceutical applications because they can specifically bind to any molecular target in the body such as proteins, viruses, bacteria and cells.
Once DNA aptamers are artificially generated for each target, they will bind to it and inhibit its activity. This makes DNA aptamers a promising technology for disease detection and drug delivery. But no DNA aptamers have been approved for clinical use yet because current aptamers do not bind well to molecular targets and are easily digested by enzymes.
“To overcome these challenges, we have created a DNA aptamer with strong binding ability and stability with superior efficacy. We hope to use our DNA aptamers as the platform technology for diagnostics and new drug development,” said IBN Executive Director Professor Jackie Y. Ying.
This study, led by IBN Principal Research Scientist and Team Leader Dr Ichiro Hirao, was recently published in the journal, Scientific Reports.
To tackle the weak binding problem, the research team added a new artificial component called unnatural base to a standard DNA aptamer, which typically has four components. The addition of the fifth component greatly enhanced the binding ability to the molecular target by 100 times as compared to conventional DNA aptamers. Furthermore, to prevent the aptamer from being digested easily by enzymes, a unique and small DNA called ‘mini-hairpin DNA’ was added to the DNA aptamer.
Dr Hirao explained, “The mini-hairpin DNAs have an unusually stable and compact stem-loop structure, like a hairpin, of small DNA fragments. Their structure strongly resists the digestive enzymes, so I added them to specific positions on the DNA aptamer to act as a protective shield. Usually DNAs are digested within one hour in blood at body temperature. With the mini-hairpin DNA, our DNA aptamers can survive for days instead of hours. This is important for pharmaceutical applications, which require the therapeutic to remain in the body for a longer period.”
If successfully commercialized, DNA aptamers could replace or complement the existing use of antibodies in drugs for targeted disease treatment. Like aptamers, antibodies bind to targets in the body, but often cause undesirable immune response and are not easy to mass produce with high quality.
“We can now generate very promising DNA aptamers for clinical use. Our aptamers are more efficient, and lower in cost and toxicity compared to conventional methods. The next step of our research is to use the aptamers to detect and deactivate target molecules and cells that cause infectious diseases, such as dengue, malaria and Methicillin-resistant Staphylococcus aureus, as well as cancer,” added Dr Hirao.
The Latest on: DNA technology
via Google News
The Latest on: DNA technology
- PharmaJet Partner Zydus Cadila Seeks EUA on World’s First Plasmid DNA COVID-19 Vaccineon July 7, 2021 at 7:12 am
The ZyCoV-D vaccine is the first ever plasmid DNA vaccine for human use and represents a key milestone in scientific innovation and technology advancement. It is delivered intradermally using the ...
- The Need for Efficiencies in the DNA Cleanup Workflowon July 7, 2021 at 6:46 am
Technology Networks spoke with Brittany Niccum to learn about the limitations of column-based DNA cleanup – a key technique used in genetic engineering – and explore alternative, modernized options.
- Cryptographic technique can preserve genetic privacy in criminal DNA profilingon July 7, 2021 at 6:10 am
Crime scene DNA analysis can help identify perpetrators, but current methods may divulge the genetic information of innocent people. Cryptography can protect genetic privacy without hampering law ...
- To Make Memories, DNA Must Breakon July 7, 2021 at 2:05 am
The quick expression of genes needed for learning and memory causes neurons to snap both strands of DNA in many more places and cell types than previously realized.
- A Pioneer Of Cell-Free Genome Technology Is Unlocking Biology's Potentialon July 6, 2021 at 6:00 am
Biology is no longer being hampered by the cell environment thanks to cell-free technology that makes it easier to clone DNA.
- FabricNano raises $12.5M to help scale its cell-free fossil fuel alternative technologyon July 6, 2021 at 4:45 am
It’s not often that you hear DNA described as a wafer – but that’s the analogy that Grant Aarons, the founder of FabricNano, a cell-free biomanufacturing company uses to describe his company’s major ...
- ISS researchers repaired DNA in space using CRISPR/Cas9 genome editingon July 5, 2021 at 4:52 am
Researchers aboard the ISS have announced the first successful use in space for a new technique for studying DNA repair in yeast. Astronauts aboard the space station have demonstrated a successful ...
- G-quadruplex-forming DNA molecules enhance enzymatic activity of myoglobinon July 1, 2021 at 10:28 am
A collaboration led by Distinguished Professor Dr. Kazunori Ikebukuro from Tokyo University of Agriculture and Technology (TUAT), Japan, discovered that G-quadruplex (G4)-forming DNA binds myoglobin ...
- DNA Digital Data Storage Market Strategies, Growth and Technology Advancement Outlook 2029on June 30, 2021 at 3:47 am
Research Nester published a report titled "DNA Digital Data Storage Market: Global Demand Analysis & Opportunity Outlook 2029" which delivers detailed overview of theglobalDNA digital data storage ...
- Investigators battling time, weather and fire to gather DNA to identify Surfside condo collapse victimson June 29, 2021 at 3:17 pm
DNA identification has improved, partly because of work to identify victims of the 9/11 attack on the World Trade Center.
via Bing News